Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunotherapy, Adoptive | 25 | 2024 | 1512 | 2.550 |
Why?
|
Receptors, Antigen, T-Cell | 7 | 2024 | 2568 | 0.940 |
Why?
|
Hematologic Neoplasms | 5 | 2024 | 1907 | 0.920 |
Why?
|
Graft vs Host Disease | 3 | 2022 | 3049 | 0.880 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2022 | 41 | 0.790 |
Why?
|
Hematopoietic Stem Cell Transplantation | 6 | 2024 | 5717 | 0.690 |
Why?
|
Hematologic Diseases | 2 | 2023 | 498 | 0.670 |
Why?
|
Communication Barriers | 1 | 2020 | 419 | 0.550 |
Why?
|
Professional-Family Relations | 1 | 2020 | 501 | 0.530 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2022 | 3626 | 0.500 |
Why?
|
Lymphoma, B-Cell | 1 | 2020 | 945 | 0.440 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2017 | 494 | 0.430 |
Why?
|
T-Lymphocytes | 18 | 2024 | 10266 | 0.430 |
Why?
|
Neurotoxicity Syndromes | 2 | 2023 | 302 | 0.300 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2023 | 271 | 0.290 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3269 | 0.280 |
Why?
|
Glioblastoma | 4 | 2024 | 3464 | 0.260 |
Why?
|
Communication | 1 | 2020 | 3905 | 0.260 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2830 | 0.250 |
Why?
|
Bone Marrow Transplantation | 2 | 2024 | 2709 | 0.230 |
Why?
|
Interleukin-7 | 1 | 2023 | 146 | 0.210 |
Why?
|
Transplantation Conditioning | 2 | 2020 | 1601 | 0.210 |
Why?
|
B-Cell Maturation Antigen | 1 | 2024 | 149 | 0.210 |
Why?
|
GPI-Linked Proteins | 1 | 2024 | 472 | 0.200 |
Why?
|
Central Nervous System Neoplasms | 2 | 2022 | 928 | 0.200 |
Why?
|
Lymphoma | 2 | 2022 | 1898 | 0.190 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2024 | 3612 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5704 | 0.180 |
Why?
|
Endopeptidases | 1 | 2024 | 764 | 0.170 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 299 | 0.170 |
Why?
|
Hospital Departments | 1 | 2020 | 135 | 0.170 |
Why?
|
Translating | 1 | 2020 | 144 | 0.160 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13677 | 0.160 |
Why?
|
Pancytopenia | 1 | 2019 | 102 | 0.160 |
Why?
|
Humans | 38 | 2024 | 768171 | 0.150 |
Why?
|
Cyclophosphamide | 2 | 2023 | 2227 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 1406 | 0.140 |
Why?
|
Transduction, Genetic | 1 | 2020 | 899 | 0.140 |
Why?
|
Lentivirus | 1 | 2020 | 518 | 0.140 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2019 | 210 | 0.140 |
Why?
|
Neoplasms | 3 | 2023 | 22371 | 0.140 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 960 | 0.140 |
Why?
|
Telephone | 1 | 2020 | 630 | 0.140 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 204 | 0.130 |
Why?
|
Tandem Repeat Sequences | 1 | 2017 | 183 | 0.130 |
Why?
|
Antigens, Neoplasm | 2 | 2024 | 1996 | 0.130 |
Why?
|
Multiple Myeloma | 2 | 2024 | 5196 | 0.130 |
Why?
|
Sulfonamides | 1 | 2024 | 1982 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1901 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1375 | 0.110 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2017 | 658 | 0.110 |
Why?
|
Autoantibodies | 1 | 2022 | 2121 | 0.110 |
Why?
|
Drug Approval | 1 | 2020 | 821 | 0.110 |
Why?
|
Flow Cytometry | 1 | 2024 | 5902 | 0.110 |
Why?
|
Biological Products | 1 | 2022 | 947 | 0.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1437 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1673 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 2012 | 408 | 0.090 |
Why?
|
Hodgkin Disease | 1 | 2019 | 1384 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3948 | 0.090 |
Why?
|
Antigens, CD19 | 2 | 2022 | 446 | 0.080 |
Why?
|
Apoptosis | 1 | 2024 | 9527 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2020 | 3800 | 0.070 |
Why?
|
Cell Line, Tumor | 4 | 2024 | 17142 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5442 | 0.070 |
Why?
|
Skin | 1 | 2019 | 4505 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9262 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11244 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8542 | 0.060 |
Why?
|
Antigens, CD7 | 1 | 2024 | 29 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11878 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13668 | 0.050 |
Why?
|
Cytokines | 3 | 2023 | 7452 | 0.050 |
Why?
|
bcl-X Protein | 1 | 2024 | 412 | 0.050 |
Why?
|
Bone Marrow | 2 | 2024 | 2935 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5341 | 0.050 |
Why?
|
France | 1 | 2023 | 497 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8052 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2022 | 3214 | 0.040 |
Why?
|
Transgenes | 1 | 2024 | 1016 | 0.040 |
Why?
|
Adult | 7 | 2024 | 223646 | 0.040 |
Why?
|
Ubiquitination | 1 | 2023 | 1009 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2022 | 557 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2024 | 1027 | 0.040 |
Why?
|
Mice | 5 | 2024 | 82049 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2019 | 287 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9118 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4363 | 0.030 |
Why?
|
Cell Death | 1 | 2022 | 1680 | 0.030 |
Why?
|
United States | 2 | 2023 | 73039 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2004 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1854 | 0.030 |
Why?
|
Exanthema | 1 | 2019 | 503 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2019 | 1836 | 0.030 |
Why?
|
Tissue Donors | 1 | 2024 | 2381 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9419 | 0.030 |
Why?
|
Child | 2 | 2023 | 80917 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1230 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 65379 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23648 | 0.030 |
Why?
|
Antigens, CD | 1 | 2024 | 4035 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2019 | 81760 | 0.030 |
Why?
|
Animals | 5 | 2024 | 169285 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3161 | 0.030 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2024 | 1756 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 223487 | 0.030 |
Why?
|
Infusions, Intra-Arterial | 1 | 2012 | 220 | 0.030 |
Why?
|
Mutation | 1 | 2017 | 30237 | 0.030 |
Why?
|
Fever | 1 | 2019 | 1614 | 0.020 |
Why?
|
Recurrence | 1 | 2024 | 8509 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2024 | 4528 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2024 | 5151 | 0.020 |
Why?
|
Hepatic Artery | 1 | 2012 | 232 | 0.020 |
Why?
|
Aged | 5 | 2024 | 171502 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4648 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3437 | 0.020 |
Why?
|
Male | 6 | 2024 | 364731 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6792 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7876 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2024 | 6395 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 7073 | 0.020 |
Why?
|
Female | 5 | 2024 | 397187 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21538 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13013 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11677 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74944 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 60066 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 89169 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2012 | 59626 | 0.000 |
Why?
|
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(74)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_